Details for New Drug Application (NDA): 080021
✉ Email this page to a colleague
NDA 080021 describes CETAMIDE, which is a drug marketed by Alcon and is included in one NDA. Additional details are available on the CETAMIDE profile page.
The generic ingredient in CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
The generic ingredient in CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 080021
| Tradename: | CETAMIDE |
| Applicant: | Alcon |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080021
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
